Conquering Diseases

Study Of An Investigational Drug For Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Or Non-Hodgkin Lymphoma


Seeking men and women who have a type of cancer that affects the B-cells (a type of white blood cells) in your blood that has not responded to, or who could not tolerate, the standard treatments normally given for this type of cancer for a study of an investigational drug.


Participants in this study will be assigned to a dose level based on when they join the study. The investigational drug will be given on 28-day cycles for 24 cycles.

What we're hoping for

We are studying the maximum dose of an investigational drug that can be safely given to people with B-cell cancers such as Chronic Lymphocytic Leukemia, small lymphocytic lymphoma or non-Hodgkin lymphoma

Additional Information Identifier: NCT05602363

 Principal Investigator

Andrew  Gillis-Smith, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655